Vistagen Therapeutics implements 31% workforce reduction on October 26, 2026
VTGN•Vistagen Therapeutics implemented a 31% workforce reduction on October 26, expected to save $3.20 million in annual salary and benefits costs, with about $1 million in severance and termination costs.
1. Workforce reduction
Vistagen Therapeutics implemented the 31% workforce reduction on October 26, according to an SEC filing. The company expects annual salary and benefits savings of $3.20 million and estimates severance and termination costs of about $1 million.
